0001493152-24-008916.txt : 20240305
0001493152-24-008916.hdr.sgml : 20240305
20240305200030
ACCESSION NUMBER: 0001493152-24-008916
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230822
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lee Ann
CENTRAL INDEX KEY: 0001953080
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41583
FILM NUMBER: 24723785
MAIL ADDRESS:
STREET 1: C/O COYA THERAPEUTICS, INC.
STREET 2: 5850 SAN FELIPE ST., SUITE 500
CITY: HOUSTON
STATE: TX
ZIP: 77057
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Coya Therapeutics, Inc.
CENTRAL INDEX KEY: 0001835022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12645 MEMORIAL DR., SUITE F1 #305
CITY: HOUSTON
STATE: TX
ZIP: 77024
BUSINESS PHONE: 650.739.3939
MAIL ADDRESS:
STREET 1: 12645 MEMORIAL DR., SUITE F1 #305
CITY: HOUSTON
STATE: TX
ZIP: 77024
4
1
ownership.xml
X0508
4
2023-08-22
0
0001835022
Coya Therapeutics, Inc.
COYA
0001953080
Lee Ann
5850 SAN FELIPE ST., SUITE 500
HOUSTON
TX
77057
1
0
0
0
0
Common Stock, par value $0.0001 per share
2023-08-22
4
P
0
1000
3.62
A
17479
I
By Spouse IRA
Represents the weighted average purchase price. The actual purchase prices range from $3.59 to $3.63 per share. The Reporting Person will supply the SEC, the Issuer, or a security holder of the Issuer, with full information regarding the number of shares at each price upon request.
/s/ David Snyder, Attorney-in-Fact
2024-03-05